CLINICAL_TRIALS
trial_result
· 2024-10-29
Clinical Trial Update: A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients [NA]
Summary
Completed longitudinal evaluation of oculometric measures and clinical assessment in Parkinson disease patients, sponsored by NeuraLight.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: NeuraLight | Conditions: Parkinson Disease | NA | Status: COMPLETED